152 related articles for article (PubMed ID: 26734002)
21. Partial protection against chlamydial reproductive tract infection by a recombinant major outer membrane protein/CpG/cholera toxin intranasal vaccine in the guinea pig Chlamydia caviae model.
Andrew DW; Hafner LM; Beagley KW; Timms P
J Reprod Immunol; 2011 Sep; 91(1-2):9-16. PubMed ID: 21856018
[TBL] [Abstract][Full Text] [Related]
22. A chlamydial major outer membrane protein extract as a trachoma vaccine candidate.
Campos M; Pal S; O'Brien TP; Taylor HR; Prendergast RA; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1477-91. PubMed ID: 7601629
[TBL] [Abstract][Full Text] [Related]
23. Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection.
Marks E; Verolin M; Stensson A; Lycke N
Infect Immun; 2007 Sep; 75(9):4638-47. PubMed ID: 17635872
[TBL] [Abstract][Full Text] [Related]
24. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.
Singh SR; Hulett K; Pillai SR; Dennis VA; Oh MK; Scissum-Gunn K
Vaccine; 2006 Feb; 24(8):1213-24. PubMed ID: 16194585
[TBL] [Abstract][Full Text] [Related]
25. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis.
Santosuosso M; McCormick S; Zhang X; Zganiacz A; Xing Z
Infect Immun; 2006 Aug; 74(8):4634-43. PubMed ID: 16861651
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.
Ifere GO; He Q; Igietseme JU; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Eko FO
J Microbiol Immunol Infect; 2007 Jun; 40(3):188-200. PubMed ID: 17639158
[TBL] [Abstract][Full Text] [Related]
27. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
[TBL] [Abstract][Full Text] [Related]
28. A TriAdj-Adjuvanted
Proctor J; Stadler M; Cortes LM; Brodsky D; Poisson L; Gerdts V; Smirnov AI; Smirnova TI; Barua S; Leahy D; Beagley KW; Harris JM; Darville T; Käser T
Vaccines (Basel); 2024 Apr; 12(4):. PubMed ID: 38675805
[No Abstract] [Full Text] [Related]
29. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes.
Macmillan L; Ifere GO; He Q; Igietseme JU; Kellar KL; Okenu DM; Eko FO
FEMS Immunol Med Microbiol; 2007 Feb; 49(1):46-55. PubMed ID: 17094789
[TBL] [Abstract][Full Text] [Related]
30. Dendritic cells (DCs) transfected with a recombinant adenovirus carrying chlamydial major outer membrane protein antigen elicit protective immune responses against genital tract challenge infection.
Lü H; Wang H; Zhao HM; Zhao L; Chen Q; Qi M; Liu J; Yu H; Yu XP; Yang X; Zhao WM
Biochem Cell Biol; 2010 Aug; 88(4):757-65. PubMed ID: 20651849
[TBL] [Abstract][Full Text] [Related]
31. Parenteral vaccination protects against transcervical infection with
Nguyen NDNT; Olsen AW; Lorenzen E; Andersen P; Hvid M; Follmann F; Dietrich J
NPJ Vaccines; 2020; 5(1):7. PubMed ID: 31993218
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection.
Jiang P; Du W; Xiong Y; Lv Y; Feng J; Zhu S; Xue X; Chen S; Zhang L
Oncotarget; 2015 Dec; 6(41):43281-92. PubMed ID: 26657117
[TBL] [Abstract][Full Text] [Related]
33. Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model.
Hansen J; Jensen KT; Follmann F; Agger EM; Theisen M; Andersen P
J Infect Dis; 2008 Sep; 198(5):758-67. PubMed ID: 18652549
[TBL] [Abstract][Full Text] [Related]
34. Enhanced immunity and protective efficacy against SIVmac251 intrarectal challenge following ad-SIV priming by multiple mucosal routes and gp120 boosting in MPL-SE.
Pinczewski J; Zhao J; Malkevitch N; Patterson LJ; Aldrich K; Alvord WG; Robert-Guroff M
Viral Immunol; 2005; 18(1):236-43. PubMed ID: 15802969
[TBL] [Abstract][Full Text] [Related]
35. CTA1-DD is an effective adjuvant for targeting anti-chlamydial immunity to the murine genital mucosa.
Cunningham KA; Carey AJ; Lycke N; Timms P; Beagley KW
J Reprod Immunol; 2009 Jul; 81(1):34-8. PubMed ID: 19501917
[TBL] [Abstract][Full Text] [Related]
36. Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses.
Huang X; Liu L; Ren L; Qiu C; Wan Y; Xu J
Vaccine; 2007 Dec; 25(52):8874-84. PubMed ID: 18061316
[TBL] [Abstract][Full Text] [Related]
37. Intrauterine inoculation of minipigs with Chlamydia trachomatis during diestrus establishes a longer lasting infection compared to vaginal inoculation during estrus.
Lorenzen E; Follmann F; Secher JO; Goericke-Pesch S; Hansen MS; Zakariassen H; Olsen AW; Andersen P; Jungersen G; Agerholm JS
Microbes Infect; 2017 Jun; 19(6):334-342. PubMed ID: 28189786
[TBL] [Abstract][Full Text] [Related]
38. Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses.
Gallorini S; Taccone M; Bonci A; Nardelli F; Casini D; Bonificio A; Kommareddy S; Bertholet S; O'Hagan DT; Baudner BC
Vaccine; 2014 Apr; 32(20):2382-8. PubMed ID: 24434044
[TBL] [Abstract][Full Text] [Related]
39. Immunologic uniqueness of the genital tract: challenge for vaccine development.
Mestecky J; Moldoveanu Z; Russell MW
Am J Reprod Immunol; 2005 May; 53(5):208-14. PubMed ID: 15833098
[TBL] [Abstract][Full Text] [Related]
40. Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice.
Akagi T; Kawamura M; Ueno M; Hiraishi K; Adachi M; Serizawa T; Akashi M; Baba M
J Med Virol; 2003 Feb; 69(2):163-72. PubMed ID: 12683403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
